Searched for
CIPLA FOUNDATION
Is India Inc's CSR truly driving systemic change or just shifting funds?Corporate India is entering a new phase of CSR. Spending is expected to cross ₹1.2 lakh crore by 2035. Companies are shifting towards syste...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Cohance Lifesciences shares rocket 43% in just 2 trading sessions. Here’s what is fuelling the surgeCohance Lifesciences shares surged over 43% in two days following the appointment of former Cipla CEO Umang Vohra as Executive Chairman and...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Most difficult: Staying invested in businesses while ignoring noise called Gulf war; 19 stocks from different sectors to ‘hold’Businesses that create long-term wealth are those where the demand runway is long, the competitive position is strong, and the management i...
- Cipla Foundation, Tata IISc launch centre for advanced pulmonary care & researchCipla Foundation and IISc are joining forces to create a new Centre for Pulmonary Medicine in Bengaluru. This facility will offer advanced ...
- Cipla global CEO Umang Vohra to step down; Achin Gupta to take overCipla's global CEO Umang Vohra will step down in March 2026. Achin Gupta, currently global COO, will take over as the new MD and GCEO from ...
- Cipla Q1 Results: Cons PAT soars 45% YoY to Rs 996 crore, beats estimatesConsolidated operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), grew by 31% on year ...
- India's shortage of remdesivir is easing, Goa plant to ramp up production: CiplaRemdesivir, made by U.S.-based Gilead Sciences Inc, has been in high demand globally, and a handful of companies including Cipla are author...
- Delhi High Court quashes Cipla's appeal, says it can't market generics of Novartis' OnbrezThe court said it can't make a definitive conclusion that Novartis' imports of Onbrez were insufficient to meet the demands COPD patients f...
- Cipla partners with non-profit body FIND to increase detection of Hepatitis CThe organisation works on accelerating development and delivery of affordable diagnostic tests for poverty-related diseases.
- NGO FIND, Cipla tie-up for Hepatitis C treatment in India"Partnering with leading doctors in the field of liver disease, Cipla has been able to provide treatment to thousands of patients over the ...
- Can co-invest with government in health: Cipla's Subhanu SaxenaOver the 2-year period with Subhanu Saxena at the helm, Cipla's revenues have grown by over 30% to nearly Rs 11,500 crore.
- Cipla bags Rs 1,100 crore order from South African governmentCipla Medpro, the SA subsidiary of the Indian firm, has bagged the order as part of the South African government's 2015-17 National ARV ten...
- Anti-AIDS blitz sees pharma firms locked in ugly battleIt has now emerged that Aids Healthcare Foundation (AHF), the US-based NGO that accused Cipla of over pricing anti-AIDS drug, Viraday, in I...
- Cipla notice to US NGO on AIDS drugDomestic major Cipla has sent a legal notice to the AIDS Healthcare Foundation, the US-based NGO which has alleged that the Indian company ...
- MRTPC lens on Cipla’s AIDS drugs for AfricaThe Monopolies and Restrictive Trade Practices Commission (MRTPC) has asked its investigation wing to probe a US-based NGO’s allegation tha...
- Cipla under MRTPC scanner for HIV drug 'overpricing'MRTPC has directed its investigative arm to probe the alleged overpricing of HIV drug 'Viraday' by Cipla.
- RK Bammi is Sami group chairmanDr RK Bammi, a member of the board of directors of Sami Labs, Bangalore, has been appointed as the chairman of the Sami Group of Companies.
- Cipla, Matrix tie up with Clinton FoundationIndian pharma companies have recorded one more international success. Domestic pharma companies Cipla and Matrix have entered into a tie-up...
Load More
